Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections

PD Tamma, EL Heil, JA Justo… - Clinical infectious …, 2024 - academic.oup.com
Abstract Background The Infectious Diseases Society of America (IDSA) is committed to
providing up-to-date guidance on the treatment of antimicrobial-resistant (AMR) infections …

Resistance to ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam in Gram-negative MDR bacilli: molecular mechanisms and susceptibility …

P Gaibani, T Giani, F Bovo, D Lombardo, S Amadesi… - Antibiotics, 2022 - mdpi.com
Multidrug resistance (MDR) represents a serious global threat due to the rapid global spread
and limited antimicrobial options for treatment of difficult-to-treat (DTR) infections sustained …

[HTML][HTML] Resistance to ceftazidime–avibactam and underlying mechanisms

Y Wang, J Wang, R Wang, Y Cai - Journal of global antimicrobial resistance, 2020 - Elsevier
Abstract Objective Ceftazidime–avibactam (CAZ-AVI) is a novel synthetic β-lactamase
inhibitor combination. Although the combination has been available clinically for only a few …

OXA-48-like β-lactamases: global epidemiology, treatment options, and development pipeline

SE Boyd, A Holmes, R Peck… - Antimicrobial agents …, 2022 - Am Soc Microbiol
Modern medicine is threatened by the rising tide of antimicrobial resistance, especially
among Gram-negative bacteria, where resistance to β-lactams is most often mediated by β …

β-Lactam antibiotic targets and resistance mechanisms: from covalent inhibitors to substrates

M Mora-Ochomogo, CT Lohans - RSC Medicinal Chemistry, 2021 - pubs.rsc.org
The β-lactams are the most widely used antibacterial agents worldwide. These antibiotics, a
group that includes the penicillins and cephalosporins, are covalent inhibitors that target …

Resistance to novel β-lactam–β-lactamase inhibitor combinations: the “price of progress”

KM Papp-Wallace, AR Mack, MA Taracila… - Infectious Disease …, 2020 - id.theclinics.com
As a class, the b-lactams are the most commonly prescribed and clinically dependable
antimicrobials in the United States, representing more than 65% of injected antibiotic …

Current and future perspectives in the treatment of multidrug-resistant Gram-negative infections

M Bassetti, J Garau - Journal of Antimicrobial Chemotherapy, 2021 - academic.oup.com
Microbial resistance is a serious threat to human health worldwide. Among the World Health
Organisation's list of priority resistant bacteria, three are listed as critical—the highest level of …

Epistasis arises from shifting the rate-limiting step during enzyme evolution of a β-lactamase

C Fröhlich, HA Bunzel, K Buda, AJ Mulholland… - Nature Catalysis, 2024 - nature.com
Epistasis, the non-additive effect of mutations, can provide combinatorial improvements to
enzyme activity that substantially exceed the gains from individual mutations. Yet the …

[HTML][HTML] The role of the natural aquatic environment in the dissemination of extended spectrum beta-lactamase and carbapenemase encoding genes: a scoping …

B Hooban, A Joyce, K Fitzhenry, C Chique, D Morris - Water Research, 2020 - Elsevier
The natural aquatic environment is a significant contributor to the development and
circulation of clinically significant antibiotic resistance genes (ARGs). The potential for the …

Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections

B Isler, AT Aslan, M Akova, P Harris… - Expert review of anti …, 2022 - Taylor & Francis
Introduction OXA-48 and NDM are amongst the most prevalent carbapenemase types
associated with Klebsiella pneumoniae worldwide, with an increase in their prevalence in …